期刊文献+

产AmpC酶及或产超广谱β-内酰胺酶的阴沟肠杆菌的检测及耐药性研究 被引量:8

Detection and resistance research of producing AmpC β-lactamases or ESBLs in Enterobacter cloacae
下载PDF
导出
摘要 目的了解阴沟肠杆菌产AmpC酶或同时产超广谱β-内酰胺酶(ESBLs)的临床现状,检测阴沟肠杆菌对常用13种抗生素的耐药性,以指导临床合理选择抗生素。方法采用三维实验确证产AmpC酶和产ESBLs菌株;用纸片扩散法进行耐药性检测。结果分离出阴沟肠杆菌120株,AmpC酶菌株检出率为20.0%(24/120),ESBLs菌株检出率为25.0%(30/120),同时产AmpC酶和ESBLs即SSBL检出率为12.5%(15/120)。阴沟肠杆菌SSBL菌株对左氧氟沙星、头孢吡肟和氨曲南的耐药率高于单产AmpC酶的菌株,差异具有统计学意义(P<0.05);SSBL菌株对亚胺培南、头孢西丁、环丙沙星的耐药率高于ESBLs菌株,差异有统计学意义(P<0.05);SSBL菌株对亚胺培南、头孢吡肟、头孢曲松、环丙沙星的耐药率高于不产AmpC酶及ESBLs即SSBL阴性的菌株,差异具有统计学意义(P<0.05)。结论AmpC酶和ESBLs是导致阴沟肠杆菌对第3代头孢菌素耐药的重要原因,SSBL菌株的流行增强了此类菌株的耐药性,治疗阴沟肠杆菌感染时应以耐药检测结果为依据,可根据药敏结果考虑选用碳青酶烯类、喹诺酮类抗生素。 Objective To investigate the clinical circumstance of Enterobacter cloacae producing AmpC β-lactamases or AmpC β-lactamases plus extended-spectrum β-lactamases(ESBLs), to assay the antimicrobial resistance of 13 drugs clinically in order to guide the appropriate choice to treat the infections caused by enterobacter cloacae.Methods AmpC β-lactamases and ESBLs producing clinical isolates were detected by three-dimensional extraction test, and the susceptibility test was detected by Kirby-Bauer(K-B).ResultsAmo...
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2008年第21期3096-3099,共4页 China Journal of Modern Medicine
关键词 阴沟肠杆菌 AMPC酶 超广谱Β-内酰胺酶 SSBL 耐药性 enterobacter cloacae AmpC β-lactamases extended-spectrum β-lactamases SSBL resistance
  • 相关文献

参考文献5

二级参考文献26

  • 1[1]Philip ED, Nancy DH, Micheal WC. Occurrence of extended-spectrum and AmpC β-lactamases in bloodstream isolates of Klebiella pneumonia: isolates harbor plasmid-mediated FOX-5 and ACT-1AmpCβ-lactamases[J]. J Clin Micro, 2003, 41: 2772-2777.
  • 2[2]Yan Jing-jou, Ko Wen-chien, Jung Yun-chih, et al. Emergence of Klebsiella pneumonia isolates produing DHA-1β-lactamases in a university hospital Taiwan[J]. J Clin Micro, 2002, 4: 3121-3126.
  • 3[3]Bradford PA, Urban C. Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid mediated AmpCβ-lactamases, and the loss of an outer membrane protein[J].Antimicrob Agents Chemother, 1997, 41(3): 563-569.
  • 4[4]Philip E, Condron E S Moland, et al. Occurrence and detection of AmpCβ-lactamases among Eschrichia coli, Klebsiella pneumoniae and proteus mirabilis solates at a veterans medical center[J]. J Clin Microbiol, 2000, 38(5): 1791-1793.
  • 5[5]Phiipon A, Arlet G, Jacoby GA. Plasmid-determined AmpC-typeβ-lactamases[J]. Antimicrob Agents Chemother, 2002, 46: 1-11.
  • 6[6]Medeiros A. Evolution and dissemination ofβ-lactamases accelerated by generations of β-lactam antibiotics[J]. Clin Infect Dis, 1997, 24:19-45.
  • 7Jones RN.Important and emerging β-lactamase-mediated resistance in hospital-based pathogens :the Amp C enzymes[J].Diagn Microbiol Infect Dis ,1998 ;31:461 -466.
  • 8Garcia-Rodriguez JA ,Jones RN ,MYSTIC Programme Study Group.Antimicrobial resistance in gram-negative isolates from European intensive care units: data from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) programme [J].J Chemother,2002 ;14:25-32.
  • 9Philippon A ,Arlet G ,Jacoby GA .Plasmid- determined AmpC-type β-lactamase[J].Antimicrob Agents Chemother,2002 ;46:1-11.
  • 10Pfaller MA ,Jones RN .Antimicrobial susceptibility of inducible AmpC beta-lactamase-producing Enterobacteriaceae from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) Pro gramme,Eurppe 1997-2000 [J].Int J Antimicrob Agents,2002; 19:383-388.

共引文献111

同被引文献55

引证文献8

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部